TipRanks
Advertisement
Advertisement

CH:DOCM Stock Latest News

DocMorris Secures Oversubscribed CHF 96.8 Million Convertible Bond on Improved Terms
Company AnnouncementsDocMorris Secures Oversubscribed CHF 96.8 Million Convertible Bond on Improved Terms
12d ago
DocMorris Raises CHF 100 Million in Oversubscribed 2031 Convertible Bond to Refinance 2028 Notes
PremiumCompany Announcements
DocMorris Raises CHF 100 Million in Oversubscribed 2031 Convertible Bond to Refinance 2028 Notes
14d ago
DocMorris Refinances 2028 Convertible With New CHF 100 Million Issue
PremiumCompany Announcements
DocMorris Refinances 2028 Convertible With New CHF 100 Million Issue
15d ago
DocMorris downgraded to Hold from Buy at Jefferies
PremiumThe Fly
DocMorris downgraded to Hold from Buy at Jefferies
29d ago
DocMorris price target raised to CHF 12.50 from CHF 11.50 at Deutsche Bank
PremiumThe Fly
DocMorris price target raised to CHF 12.50 from CHF 11.50 at Deutsche Bank
1M ago
DocMorris AG Earnings Call Signals AI‑Driven Turnaround
PremiumCompany AnnouncementsDocMorris AG Earnings Call Signals AI‑Driven Turnaround
1M ago
DocMorris: Buy Rating Reaffirmed as Fundamentals Improve, Price Target Unchanged at CHF9.50
Premium
Ratings
DocMorris: Buy Rating Reaffirmed as Fundamentals Improve, Price Target Unchanged at CHF9.50
1M ago
DocMorris Lifts 2026 Outlook on Surging Rx and Digital Services
Premium
Company Announcements
DocMorris Lifts 2026 Outlook on Surging Rx and Digital Services
1M ago
DocMorris upgraded to Neutral from Sell at UBS
PremiumThe Fly
DocMorris upgraded to Neutral from Sell at UBS
2M ago
DocMorris: Strong Rx Momentum and AI Strategy Support Buy Rating as CHF 9.50 Price Target Remains Unchanged
PremiumRatings
DocMorris: Strong Rx Momentum and AI Strategy Support Buy Rating as CHF 9.50 Price Target Remains Unchanged
2M ago
DocMorris accelerates Rx and digital growth, tracks toward 2026 EBITDA breakeven
PremiumCompany Announcements
DocMorris accelerates Rx and digital growth, tracks toward 2026 EBITDA breakeven
2M ago
DocMorris upgraded to Buy from Hold at Deutsche Bank
PremiumThe Fly
DocMorris upgraded to Buy from Hold at Deutsche Bank
2M ago
PremiumCompany AnnouncementsDocMorris Fast-Tracks AI-First Strategy With Job Cuts and Cost Savings Plan
3M ago
Premium
Company Announcements
DocMorris shareholders back board, reaffirm digital health strategy and 2026 break-even goal
4M ago
Premium
Ratings
Buy Rating Backed by Strong 2026 Start, Balanced Segment Growth and Clear Path to Q4 Profit Break-Even
5M ago
PremiumCompany Announcements
DocMorris Q1 2026 Growth and Profitability Gains Reinforce Path to Break-Even
5M ago
PremiumCompany Announcements
DocMorris Board Urges Shareholders to Block ‘Creeping Takeover’ at May General Meeting
5M ago
DocMorris AG Charts Costly Yet Credible Turnaround
PremiumCompany Announcements
DocMorris AG Charts Costly Yet Credible Turnaround
6M ago
DocMorris price target lowered to CHF 4.45 from CHF 8.10 at Berenberg
PremiumThe Fly
DocMorris price target lowered to CHF 4.45 from CHF 8.10 at Berenberg
6M ago
DocMorris price target lowered to CHF 4.50 from CHF 7 at Deutsche Bank
PremiumThe FlyDocMorris price target lowered to CHF 4.50 from CHF 7 at Deutsche Bank
6M ago
DocMorris: Credible Turnaround and Improving EBITDA Outlook Support Buy Rating
Premium
Ratings
DocMorris: Credible Turnaround and Improving EBITDA Outlook Support Buy Rating
6M ago
DocMorris Hits 2025 Targets as It Accelerates AI-Driven Health Platform Shift
Premium
Company Announcements
DocMorris Hits 2025 Targets as It Accelerates AI-Driven Health Platform Shift
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >